Novo Nordisk A/S NVO reported third-quarter 2019 earnings of 64 cents per American Depositary Receipt (ADR), beating the Zacks Consensus Estimate of 62 cents and increasing 15% in DKK from the year-ago quarter.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,